Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702513 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
Our findings demonstrate a decrease in elevated PSA referrals, increase in PSA at the time of referral, decrease in detection of low-risk disease, and increase in detection of intermediate-/high-risk disease in a high-volume, multisite, community-based urology practice, coinciding with the United States Preventative Services Task Force recommendations against PSA screening.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Franklin D. M.D., Jae E. B.S., Zachary M.D., Paul M.D., Edward M.D., Renee L.V.N., Hilary Prime, Aaron B.S., Andrew Karim M.D., Ph.D.,